
About DigiClinics
DigiClinics is a Healthcare company based in Hyderabad (India) founded in 2017 by Devika Rubi, Raj Subramanian, and Sheikh Mukhtar. Breast cancer grading and diagnostics are enabled by AI platform. DigiClinics has raised $119.91 thousand across 2 funding rounds from investors including TIH IIT Patna. The company has 1 employees. DigiClinics was last valued at $4.45 million in June 2024. Its chief executive, as recorded, is Raj Subramanian. DigiClinics offers products and services including OncoVision, Digitized Pathology Platform, and Ultrasound and Mammography Platform. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its legal entity in India is Digiclinics Research & Services Private Limited (U73200TN2021PTC146746). Its competitors include Niramai and D3S Healthcare Technologies; 1 of its 2 listed competitors has raised funding.
Company details
Founded in 2017 and based in Hyderabad, India, DigiClinics operates in the healthcare sector with an AI-driven platform for cancer diagnostics. Services include decision support for pathologists in breast and lung cancer cases, where grading is combined with biomarker identification. Clinical workflows are streamlined to support precision medicine, with operations focused on timely treatment delivery across healthcare settings.
- Headquarters Hyderabad, India
- Employees 1
- Founders Devika Rubi, Raj Subramanian, Sheikh Mukhtar
- Stage Minicorn
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website digiclinics.in
- Social LinkedIn
- Legal Name Digiclinics Research & Services Private Limited
- Date of Incorporation 01 Oct, 2021
- Jurisdiction Tiruchirappalli, Tamil Nadu, India
- Annual Revenue₹16,536
FY 2024
- Net Loss-₹37.6 Lakh
FY 2024 · -22728% margin
- EBITDA-₹30.6 Lakh
FY 2024 · -18515% margin
- Total Equity Funding$119.91K (USD)
in 2 rounds
- Latest Funding Round$59.74K (USD), Seed
Jun 2024
- Investors
- Employee Count1
Associated legal entities of DigiClinics
DigiClinics operates through Digiclinics Research & Services Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Digiclinics Research & Services Private Limited CIN U73200TN2021PTC146746 | Active | 01 Oct 2021 | Tiruchirappalli, Tamil Nadu | ₹0.0 Cr | 2 | View details |
Products & Services of DigiClinics
DigiClinics offers a comprehensive portfolio of products and services, including OncoVision, Digitized Pathology Platform, and Ultrasound and Mammography Platform.
Platform for breast cancer diagnostics and efficient grading
Enables accurate sentinel lymph node metastasis diagnosis
Facilitates cost-effective annual breast cancer checkups
Funding Insights of DigiClinics
DigiClinics has successfully raised a total of $119.91K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $59.74 thousand completed in June 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $119,907
- Total Rounds 2
- Last Round Seed β $59,740
- First Round $60,167
(Sep 2023)
- Investors Count 1
All 2 funding rounds of DigiClinics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2024 | $59,740 | Seed | $4.45M | TIH IIT Patna | β |
| Sep 2023 | $60,167 | Seed | $4.41M | TIH IIT Patna | β |
| Date | Valuation | Stage |
|---|---|---|
| Jun 2024 | $4.45M | β’β’β’β’β’β’β’β’ |
| Sep 2023 | $4.41M | β’β’β’β’β’β’β’β’ |
Last known valuation $4.45M (Jun 2024). 1 investors in total: 1 institutional.
Investors in DigiClinics
DigiClinics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include TIH IIT Patna.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| tih-iitp.com |
Investor details for DigiClinics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Digiclinics Research & Services Private Limited (DigiClinics)
Digiclinics Research & Services Private Limited is the primary company behind DigiClinics. The board of Digiclinics Research & Services Private Limited currently have 2 directors; the longest-serving is Subramanian Rajasekaran, appointed in 2021.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Subramanian Rajasekaran DIN 07739696 | Director | 01 Oct 2021 | 5 yrs 1 mo | Digiclinics Research & Services Private Limited |
| Devika Rubi Rajasekaran DIN 09344375 | Director | 01 Oct 2021 | 5 yrs 1 mo | Digiclinics Research & Services Private Limited |
People of DigiClinics
3 people are tracked at DigiClinics (3 in leadership); the tracked headcount is 1.
| Name | Role | Group |
|---|---|---|
| Co-Founder & CSO | Leadership | |
Raj Subramanian | Co-Founder & CEO | Leadership |
Sheikh Mukhtar | Co-Founder | Leadership |
Complete people profiles for DigiClinics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of DigiClinics
Figures of Digiclinics Research & Services Private Limited, the primary company behind DigiClinics, for FY 2024. Revenue was ₹16,536. Net loss was -₹37.6 Lakh (-22728% margin). EBITDA was -₹30.6 Lakh (-18515% margin).
- ₹16,536Revenue · FY 2024
- -₹37.6 LakhNet loss · -22728% margin
- -₹30.6 LakhEBITDA · -18515% margin
- ₹1 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Digiclinics Research & Services Private Limited are on its company page.
Detailed financial statements for DigiClinics
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of DigiClinics
4 dated milestones of DigiClinics across 7 years, from founding to its latest funding, stage changes and deals.
- Founded DigiClinics is founded.
- Funding First funding round of $60K.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Seed, of $60K.
Competitors of DigiClinics
DigiClinics has 2 listed competitors in our database, 1 of them funded. They include Niramai and D3S Healthcare Technologies.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| niramai.com | 2016 | Bengaluru, India | $8.63M | 37 | Early breast cancer is detected using AI-based non-invasive thermal imaging. | |
| d3shealthcare.com | 2020 | Ahmedabad, India | Breast cancer screening devices are supplied to hospitals and clinics. |
Detailed competitors of DigiClinics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about DigiClinics
DigiClinics was founded in 2017 and raised its 1st funding round 6 years after it was founded.
DigiClinics is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Raj Subramanian is the CEO of DigiClinics, as recorded in our data. They have also founded this company.
DigiClinics is a funded company, having raised a total of $119.91K across 2 funding rounds to date. The company's 1st funding round was a Seed of $60.17K, raised on Sep 2023.
DigiClinics has 1 employees.
The primary company behind DigiClinics, Digiclinics Research & Services Private Limited, reported revenue of βΉ16,536 for FY 2024.
Founded in 2017 and based in Hyderabad, India, DigiClinics operates in the healthcare sector with an AI-driven platform for cancer diagnostics. Services include decision support for pathologists in breast and lung cancer cases, where grading is combined with biomarker identification. Clinical workflows are streamlined to support precision medicine, with operations focused on timely treatment delivery across healthcare settings.
DigiClinics's top competitors include Niramai and D3S Healthcare Technologies.
DigiClinics offers OncoVision, Digitized Pathology Platform, and Ultrasound and Mammography Platform.
DigiClinics has 1 investor. Key investors include TIH IIT Patna.
The valuation of DigiClinics is $4.45M as of Jun 2024.
DigiClinics operates through Digiclinics Research & Services Private Limited.